Research programme: hetero aromatic polycycle antibacterials - Oscient

Drug Profile

Research programme: hetero aromatic polycycle antibacterials - Oscient

Alternative Names: GSQ 10547; GSQ 11203; GSQ 2287; GSQ 5028; GSQ 7302; HARP antibacterials research programme - Oscient; Hetero aromatic polycycle antibacterials research programme - Oscient

Latest Information Update: 24 Nov 2004

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Oscient Pharmaceuticals
  • Class Small molecules
  • Mechanism of Action DNA inhibitors; RNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Bacterial infections

Most Recent Events

  • 24 Nov 2004 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
  • 13 Apr 2004 Genome Therapeutics is now called Oscient Pharmaceuticals
  • 12 Feb 2004 GeneSoft has merged with Genome Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top